HomepageEarnings Events Newsdesk 1 hour ago Neurocrine Biosciences, Inc (NBIX) Neurocrine Biosciences Presents First Real-World Head-to-Head Claims Analysis Demonstrating Greater Treatment Persistence with INGREZZA® (valbenazine) Capsules Compared to AUSTEDO XR Neurocrine Biosciences, Inc (NASDAQ: NBIX) FY 2026 Other Release Corteva, Inc (CTVA) Corteva Announces Executive Leadership Team of its Future Crop Protection Company » « GATX Corporation (GATX) Q1 2026 Earnings Call Newsdesk: